Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
Abstract Background The fractional exhaled nitric oxide (FeNO) and blood eosinophils are biomarkers of eosinophilic airway inflammation used in the diagnosis and management of asthma, although induced sputum is the gold standard test for phenotypic asthma. Nevertheless, the clinical application of t...
Main Authors: | Jie Gao, Feng Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-018-0248-7 |
Similar Items
-
Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
by: Yuki Hoshino, et al.
Published: (2022-04-01) -
Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
by: Brooks EA, et al.
Published: (2019-04-01) -
Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma
by: Katarzyna Mycroft, et al.
Published: (2023-06-01) -
IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma
by: Jorge Sánchez, et al.
Published: (2021-03-01) -
Proteomic signatures of eosinophilic and neutrophilic asthma from serum and sputumResearch in context
by: Khezia Asamoah, et al.
Published: (2024-01-01)